Calmodulin-drug interaction. A fluorescence and flow dialysis study.
Various Ca2+-antagonists and related compounds were probed for possible anti-calmodulin properties. Some of them efficiently inhibit calmodulin dependent activity (the plasma membrane Ca2+-ATPase and the cyclic nucleotide phosphodiesterase). The I50-values for the most potent inhibitors varied between 15 and 30 uM. Using fluorescence spectroscopy and flow dialysis methods the stoichiometry of the binding of some of the drugs to calmodulin has been investigated. The number of Ca2+-dependent high affinity binding sites has been studied on trypsin fragments of calmodulin. Compound 12-114 was bound with high affinity in a Ca2+-dependent way to both halves of calmodulin, compound 200-737 recognized one high affinity binding site only in the C-terminal half of the molecule, whereas compound 36-079 demanded the intact protein to be able to interact with high affinity in a Ca2+-dependent manner.
D000252:Calcium-Transporting ATPases / Q000097:blood; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D003619:Dansyl Compounds / Q000032:analysis; D003956:Dialysis; D004347:Drug Interactions; D004910:Erythrocyte Membrane / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000097:blood; D013050:Spectrometry, Fluorescence
D002147:Calmodulin; D003619:Dansyl Compounds; D010727:Phosphoric Diester Hydrolases; D000252:Calcium-Transporting ATPases; D008274:Magnesium